U.S. market Closed. Opens in 16 hours 53 minutes

ERNA | Eterna Therapeutics Inc. Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-31
Revenue68.00KN/AN/AN/A19.81M23.34M
Cost of Revenue1.36M497.00K459.00K98.00K7.84M315.00K
Gross Profit-1.29M-497.00K-459.00K-98.00K11.96M23.02M
Operating Expenses19.38M27.23M27.43M7.25M13.18M22.82M
Selling, General & Admin13.46M16.84M14.72M3.30M13.15M14.49M
Research & Development5.92M10.39M12.71M3.95M26.00KN/A
Other Operating Expenses-334.00K-1.17M899.00KN/AN/A8.33M
Operating Income-20.67M-33.22M68.34M-7.25M-1.21M203.00K
Other Expenses / Income-997.00K8.68M-190.64M-43.00K-808.00K-526.00K
Before Tax Income-21.67M-24.53M-122.30M-7.29M-2.02M-323.00K
Income Tax Expenses-3.00K45.00K5.00K-19.20M27.00K64.00K
Net Income-21.67M-24.58M-122.31M11.91M-2.05M-259.00K
Interest Expenses614.00K30.00K74.00K43.00K249.00K-389.00K
Basic Shares Outstanding5.31M3.05M2.17M439.70K71.88K2.69M
Diluted Shares Outstanding5.31M3.05M2.17M439.70K71.88K2.69M
EBITDA-19.55M-32.03M68.80M-7.15M1.96M7.49M
EBITDA Margin-28,751.47%0.00%0.00%0.00%9.88%32.08%
EBIT-21.06M-24.50M-122.23M-7.25M-1.77M-584.00K
EBIT Margin-30,966.18%0.00%0.00%0.00%-8.94%-2.50%
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙